Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial

BACKGROUND: Inhaled glucocorticosteroids (ICS) are the mainstay of treatment in asthma. Fluticasone furoate (FF) is a novel, once-daily ICS asthma therapy. This study investigated the efficacy and safety of FF 50 mcg in patients with mild-to-moderate persistent asthma. METHODS: A 24-week, multicente...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Allergy
मुख्य लेखकों: Busse, W W, Bateman, E D, O'Byrne, P M, Lötvall, J, Woodcock, A, Medley, H, Forth, R, Jacques, L
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BlackWell Publishing Ltd 2014
विषय:
Original Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329337/
https://ncbi.nlm.nih.gov/pubmed/25040613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.12480
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन